Anti-ZFPL1 monoclonal antibody

Pre-made anti-ZFPL1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ZFPL1/ZFPL1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2314-Ab-1/ GM-Tg-hg-IP2314-Ab-2Anti-Human ZFPL1 monoclonal antibodyHuman
GM-Tg-rg-IP2314-Ab-1/ GM-Tg-rg-IP2314-Ab-2Anti-Rat ZFPL1 monoclonal antibodyRat
GM-Tg-mg-IP2314-Ab-1/ GM-Tg-mg-IP2314-Ab-2Anti-Mouse ZFPL1 monoclonal antibodyMouse
GM-Tg-cynog-IP2314-Ab-1/ GM-Tg-cynog-IP2314-Ab-2Anti-Cynomolgus/ Rhesus macaque ZFPL1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2314-Ab-1/ GM-Tg-felg-IP2314-Ab-2Anti-Feline ZFPL1 monoclonal antibodyFeline
GM-Tg-cang-IP2314-Ab-1/ GM-Tg-cang-IP2314-Ab-2Anti-Canine ZFPL1 monoclonal antibodyCanine
GM-Tg-bovg-IP2314-Ab-1/ GM-Tg-bovg-IP2314-Ab-2Anti-Bovine ZFPL1 monoclonal antibodyBovine
GM-Tg-equg-IP2314-Ab-1/ GM-Tg-equg-IP2314-Ab-2Anti-Equine ZFPL1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2314-Ab-1/ GM-Tg-hg-IP2314-Ab-2; GM-Tg-rg-IP2314-Ab-1/ GM-Tg-rg-IP2314-Ab-2;
GM-Tg-mg-IP2314-Ab-1/ GM-Tg-mg-IP2314-Ab-2; GM-Tg-cynog-IP2314-Ab-1/ GM-Tg-cynog-IP2314-Ab-2;
GM-Tg-felg-IP2314-Ab-1/ GM-Tg-felg-IP2314-Ab-2; GM-Tg-cang-IP2314-Ab-1/ GM-Tg-cang-IP2314-Ab-2;
GM-Tg-bovg-IP2314-Ab-1/ GM-Tg-bovg-IP2314-Ab-2; GM-Tg-equg-IP2314-Ab-1/ GM-Tg-equg-IP2314-Ab-2
Products NameAnti-ZFPL1 monoclonal antibody
Formatmab
Target NameZFPL1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ZFPL1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2314-Ag-1Recombinant multi-species ZFPL1/ D11S750/ MCG4 protein


    Target information

    Target IDGM-IP2314
    Target NameZFPL1
    Gene ID7542,81909,684755,716932,483750,101083294,613442,100056453
    Gene Symbol and SynonymsD11S750,MCG4,ZFPL1
    Uniprot AccessionO95159,Q2YDD3
    Uniprot Entry NameZFPL1_HUMAN,ZFPL1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000162300
    Target ClassificationN/A

    The target: ZFPL1, gene name: ZFPL1, also named as D11S750, MCG4. Predicted to enable metal ion binding activity. Predicted to be involved in vesicle-mediated transport. Located in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.